Sareum Holdings PLC (SAR)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
16.00p
Buy
19.00p
-0.50p (-2.78%)
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies.
Prices updated at 09 May 2025, 16:28 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
18.49p - 16.26p | |
52.50p - 11.00p | |
- | |
24.03m | |
- | |
20,000 | |
280,346 | |
5.39 | |
456,762.49 | |
0.33 | |
107.95m | |
GB00BMC3RJ87 | |
-0.03 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.